📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study. (2022)

First Author: Alexander JL

Attributed to: The Durability of immune Responses to vaccination against SARS-CoV-2 and its Variants. funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2468-1253(22)00274-6

PubMed Identifier: 36088954

Publication URI: http://europepmc.org/abstract/MED/36088954

Type: Journal Article/Review

Volume: 7

Parent Publication: The lancet. Gastroenterology & hepatology

Issue: 11